Inmed Pharmaceuticals In (IN.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,944 | 10,313 | 4,863 | 5,158 | 2,049 |
| Marketable Securities | 1,806 | N/A | N/A | N/A | N/A |
| Receivables | 39 | 15 | 19 | 45 | 95 |
| TOTAL | $10,820 | $10,580 | $4,993 | $5,340 | $2,282 |
| Non-Current Assets | |||||
| PPE Net | 49 | 45 | 41 | 21 | 13 |
| Intangibles | 1,004 | 1,049 | 1,082 | 1,049 | 1,040 |
| TOTAL | $1,053 | $1,093 | $1,122 | $1,070 | $1,054 |
| Total Assets | $11,874 | $11,674 | $6,115 | $6,410 | $3,335 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 493 | 236 | 153 | 284 | 246 |
| TOTAL | $493 | $236 | $153 | $284 | $247 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $493 | $236 | $153 | $284 | $247 |
| Shareholders' Equity | |||||
| Common Shares | 42,056 | 35,805 | 35,507 | 33,181 | 28,407 |
| Retained earnings | -37,390 | -36,706 | -35,964 | -32,904 | -30,683 |
| Other shareholders' equity | 0 | 6,102 | 0 | 0 | 52 |
| TOTAL | $11,381 | $11,438 | $5,962 | $6,125 | $3,088 |
| Total Liabilities And Equity | $11,874 | $11,674 | $6,115 | $6,410 | $3,335 |